ChineseInvestors.com, Inc.’s (CIIX) CBD Biotechn
Post# of 346
(Total Views: 214)
Posted On: 10/10/2018 6:14:09 PM
ChineseInvestors.com, Inc.’s (CIIX) CBD Biotechnology Co. Ltd. Sets December Launch for CBD Hemp-Infused Rice Wine, Sees it as ‘Sales Driver’
- CIIX’s wholly owned foreign enterprise, CBD Biotechnology Co. Ltd. (CBD Biotech), will debut new private label wine at peak period for liquor sales in China
- Company recorded sales of $2.35 million for FY2018, up 41 percent from $1.66 million the prior year
- Summer Yun, CEO of CBD Biotech, anticipates greater volume during the top sales season for liquor
ChineseInvestors.com, Inc.’s (OTCQB: CIIX) CBD Biotech, a wholly owned foreign enterprise, plans to debut a CBD hemp-infused rice wine in December, during China’s peak holiday/festival season that includes Christmas, New Year’s, and Spring Festival (http://nnw.fm/Y7T4f).
In a news release, Warren Wang, CEO of CIIX, said, “Moving forward, CBD Biotech plans to explore a variety of hemp products, in addition to its skin-care and alcoholic beverage products. We believe the upcoming launch of CBD Hemp Wine will serve as a strong sales driver for the Company.”
The announcement comes after CIIX reported a sharp jump in its sales for FY 2018. Prior, CIIX also detailed plans to spin off its CBD division in the future. The division includes CBD Biotech, Hemp Logic, Inc. and ChineseHempOil.com, Inc. (http://nnw.fm/dRZ9k).
CIIX has an international Chinese-speaking audience. It has core revenue from subscriptions and consulting. Its website notes that the company expects to issue its own ICO in the second half of 2018 or in 2019 and create a virtual investment ‘ecosystem’ for its Chinese viewers (http://nnw.fm/V3cyv). Internationally, its future network of ATMs may expand into Canada from the U.S., and its bitcoin courses may be offered online to Asia.
An update note issued by SeeThruEquity last month explained that CIIX was seeking some $3 million in a private placement in August. Its analysis expects that CIIX will continue to seek external capital to cover operating costs (http://nnw.fm/KpV0U).
For more information, visit the company’s website at www.ChineseInvestors.com
Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer
- CIIX’s wholly owned foreign enterprise, CBD Biotechnology Co. Ltd. (CBD Biotech), will debut new private label wine at peak period for liquor sales in China
- Company recorded sales of $2.35 million for FY2018, up 41 percent from $1.66 million the prior year
- Summer Yun, CEO of CBD Biotech, anticipates greater volume during the top sales season for liquor
ChineseInvestors.com, Inc.’s (OTCQB: CIIX) CBD Biotech, a wholly owned foreign enterprise, plans to debut a CBD hemp-infused rice wine in December, during China’s peak holiday/festival season that includes Christmas, New Year’s, and Spring Festival (http://nnw.fm/Y7T4f).
In a news release, Warren Wang, CEO of CIIX, said, “Moving forward, CBD Biotech plans to explore a variety of hemp products, in addition to its skin-care and alcoholic beverage products. We believe the upcoming launch of CBD Hemp Wine will serve as a strong sales driver for the Company.”
The announcement comes after CIIX reported a sharp jump in its sales for FY 2018. Prior, CIIX also detailed plans to spin off its CBD division in the future. The division includes CBD Biotech, Hemp Logic, Inc. and ChineseHempOil.com, Inc. (http://nnw.fm/dRZ9k).
CIIX has an international Chinese-speaking audience. It has core revenue from subscriptions and consulting. Its website notes that the company expects to issue its own ICO in the second half of 2018 or in 2019 and create a virtual investment ‘ecosystem’ for its Chinese viewers (http://nnw.fm/V3cyv). Internationally, its future network of ATMs may expand into Canada from the U.S., and its bitcoin courses may be offered online to Asia.
An update note issued by SeeThruEquity last month explained that CIIX was seeking some $3 million in a private placement in August. Its analysis expects that CIIX will continue to seek external capital to cover operating costs (http://nnw.fm/KpV0U).
For more information, visit the company’s website at www.ChineseInvestors.com
Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer
(0)
(0)Chineseinvestors.com Inc. (CIIX) Stock Research Links
Scroll down for more posts ▼